p38 Mitogen-Activated Protein Kinase (MAPK) and Steroid Insensitivity in Asthma

计划入组 12 人 · 首次发布于 2008 年 5 月 13 日

P38 Mitogen-activated Protein (Map) Kinase Inhibitor (SB-681323)Study In Patients With Neuropathic Pain

计划入组 50 人 · 首次发布于 2006 年 10 月 20 日

Study of DCC-3084 in Participants With Advanced Malignancies Driven by the Mitogen-Activated Protein Kinase (MAPK) Pathway

计划入组 29 人 · 首次发布于 2024 年 3 月 1 日

PARP/MEK dual inhibitors (MD Anderson)

Inhibitor of P38 Kinase

C₁₅H₁₄N₂

AMP-activated protein kinase inhibitors (Generian)

Protein Sciences Corporation

United States

Alpha Metallurgical

United States

Zeno Alpha, Inc.

United States

CervoMed's Neflamapimod Shows Promise in Dementia with Lewy Bodies

CervoMed's Neflamapimod Shows Promise in Dementia with Lewy Bodies by Targeting Neurodegenerative Activity

Kinase Inhibitors Discovered to Trigger Widespread Protein Degradation Beyond Traditional Inhibition